Kathleen Hauser

728 total citations
25 papers, 619 citations indexed

About

Kathleen Hauser is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Animal Science and Zoology. According to data from OpenAlex, Kathleen Hauser has authored 25 papers receiving a total of 619 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Cellular and Molecular Neuroscience, 16 papers in Molecular Biology and 3 papers in Animal Science and Zoology. Recurrent topics in Kathleen Hauser's work include Receptor Mechanisms and Signaling (11 papers), Neuropeptides and Animal Physiology (10 papers) and Neuroscience and Neuropharmacology Research (8 papers). Kathleen Hauser is often cited by papers focused on Receptor Mechanisms and Signaling (11 papers), Neuropeptides and Animal Physiology (10 papers) and Neuroscience and Neuropharmacology Research (8 papers). Kathleen Hauser collaborates with scholars based in Switzerland and Australia. Kathleen Hauser's co-authors include C. Anthony Altar, P. C. Waldmeier, H. Bittiger, D. J. Dooley, Serge Bischoff, P. A. Baumann, Siem J. Veenstra, L. Maître, Walter Schilling and Silvio Ofner and has published in prestigious journals such as Brain Research, Neuroscience and Biochemical Pharmacology.

In The Last Decade

Kathleen Hauser

25 papers receiving 590 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Kathleen Hauser 433 313 81 64 52 25 619
G.E. Martin 483 1.1× 254 0.8× 99 1.2× 91 1.4× 70 1.3× 34 732
Rossella Dall’Olio 449 1.0× 255 0.8× 61 0.8× 55 0.9× 83 1.6× 37 626
A. Barbara Pflueger 424 1.0× 217 0.7× 71 0.9× 65 1.0× 51 1.0× 18 637
Elizabeth Erdelyi 396 0.9× 307 1.0× 88 1.1× 23 0.4× 49 0.9× 21 678
Maggie D. Lalies 315 0.7× 247 0.8× 75 0.9× 59 0.9× 31 0.6× 17 492
C.A. Korduba 690 1.6× 523 1.7× 85 1.0× 72 1.1× 67 1.3× 24 975
Keith R. Jarvie 528 1.2× 512 1.6× 46 0.6× 58 0.9× 54 1.0× 22 749
J. Gaál 378 0.9× 289 0.9× 56 0.7× 40 0.6× 68 1.3× 27 541
P. A. Baumann 429 1.0× 269 0.9× 79 1.0× 44 0.7× 46 0.9× 18 642
Steven Z. Whetzel 443 1.0× 433 1.4× 79 1.0× 56 0.9× 29 0.6× 20 841

Countries citing papers authored by Kathleen Hauser

Since Specialization
Citations

This map shows the geographic impact of Kathleen Hauser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kathleen Hauser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kathleen Hauser more than expected).

Fields of papers citing papers by Kathleen Hauser

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kathleen Hauser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kathleen Hauser. The network helps show where Kathleen Hauser may publish in the future.

Co-authorship network of co-authors of Kathleen Hauser

This figure shows the co-authorship network connecting the top 25 collaborators of Kathleen Hauser. A scholar is included among the top collaborators of Kathleen Hauser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kathleen Hauser. Kathleen Hauser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Gerspacher, Marc, Robert Mah, Gary P. Anderson, et al.. (2000). N-[(R,R)-(E)-1-(4-chloro-benzyl)-3-(2-oxo-azepan-3-ylcarbamoyl)-allyl]-N-methyl-3,5-bis-trifluoromethyl-benzamide: an orally active neurokinin NK1/NK2 antagonist. Bioorganic & Medicinal Chemistry Letters. 10(13). 1467–1470. 9 indexed citations
3.
Vassout, A., Siem J. Veenstra, Kathleen Hauser, et al.. (2000). NKP608: a selective NK-1 receptor antagonist with anxiolytic-like effects in the social interaction and social exploration test in rats. Regulatory Peptides. 96(1-2). 7–16. 43 indexed citations
4.
Gerspacher, Marc, Gary P. Anderson, N. Subramanian, et al.. (1997). CGP57698: A Structurally Simple, Highly Potent Peptidoleukotriene (PLT) Antagonist of the Quinoline Type. Advances in experimental medicine and biology. 433. 169–172. 2 indexed citations
5.
Veenstra, Siem J., et al.. (1997). Studies on the active conformation of the NK1 antagonist CGP 49823. Part 21. Fluoro-olefin analogs of tertiary amide rotamers.. Bioorganic & Medicinal Chemistry Letters. 7(3). 351–354. 10 indexed citations
6.
Hauser, Kathleen, Jakob Heid, & H. Bittiger. (1993). [3H]Substance P binds to two high-affinity sites in bovine retina. Regulatory Peptides. 46(1-2). 340–342. 3 indexed citations
7.
Waldmeier, P. C., P. A. Baumann, J.-J. Feldtrauer, et al.. (1990). CGP 28014, a new inhibitor of cerebral catechol-O-methylation with a non-catechol structure. Naunyn-Schmiedeberg s Archives of Pharmacology. 342(3). 305–311. 34 indexed citations
8.
Hauser, Kathleen, et al.. (1989). Reversal by apomorphine of the gabaculine-induced GABA accumulation in mouse cortex. European Journal of Pharmacology. 174(2-3). 161–170. 2 indexed citations
9.
Portet, C., Markus Schmutz, H. Bittiger, et al.. (1989). CGP 31358 binds to a site on the NMDA receptor that is coupled to both the transmitter recognition site and the channel domain. Neuroscience Letters. 107(1-3). 184–188. 2 indexed citations
10.
Balcar, Vladimír J., et al.. (1989). Developmental changes in high-affinity uptake of GABA by cultured neurons. Neurochemical Research. 14(3). 229–233. 8 indexed citations
11.
Altar, C. Anthony & Kathleen Hauser. (1987). Topography of substantia nigra innervation by D1 receptor-containing striatal neurons. Brain Research. 410(1). 1–11. 121 indexed citations
12.
Waldmeier, P. C., et al.. (1986). Ifoxetine, a compound with atypical effects on serotonin uptake. European Journal of Pharmacology. 130(1-2). 1–10. 6 indexed citations
13.
Häusler, A., et al.. (1985). Effects of subchronic administration of psychoactive substances on the circadian rhythm of urinary corticosterone excretion in rats. Psychoneuroendocrinology. 10(4). 421–429. 8 indexed citations
14.
Hauser, Kathleen, Hans-Rudolf Olpe, & Roland S.G. Jones. (1985). Trimipramine, a tricyclic antidepressant exerting atypical actions on the central noradrenergic system. European Journal of Pharmacology. 111(1). 23–30. 29 indexed citations
15.
Waldmeier, P. C., P. A. Baumann, H. Bittiger, et al.. (1984). CGP 15 210 G, AN UNUSUAL INHIBITOR OF SEROTONIN (5-HT) UPTAKE. Clinical Neuropharmacology. 7. S472–S472. 1 indexed citations
16.
Bernasconi, R., W. L. Bencze, Kathleen Hauser, et al.. (1984). Protective effects of diazepam and valproate on β-vinyllactic acid-induced seizures. Neuroscience Letters. 47(3). 339–344. 6 indexed citations
17.
Dooley, D. J., Kathleen Hauser, & H. Bittiger. (1983). Differential decrease of the central beta-adrenergic receptor in the rat after subchronic infusion of desipramine and clenbuterol. Neurochemistry International. 5(3). 333–338. 22 indexed citations
18.
Dooley, D. J., H. Bittiger, Kathleen Hauser, Serge Bischoff, & P. C. Waldmeier. (1983). Alteration of central alpha2- and beta-adrenergic receptors in the rat after DSP-4, a selective noradrenergic neurotoxin. Neuroscience. 9(4). 889–898. 133 indexed citations
19.
Dooley, David & Kathleen Hauser. (1983). Subchronic infusion of clenbuterol, a beta-adrenergic agonist, decreases the cerebellar beta receptor. Neuroscience Letters. 36(1). 93–97. 20 indexed citations
20.
Waldmeier, P. C., et al.. (1982). Oxaprotiline, a noradrenaline uptake inhibitor with an active and an inactive enantiomer. Biochemical Pharmacology. 31(12). 2169–2176. 82 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by G.E. Martin Breakdown of academic impact, for papers by Rossella Dall’Olio Breakdown of academic impact, for papers by A. Barbara Pflueger Breakdown of academic impact, for papers by Elizabeth Erdelyi Breakdown of academic impact, for papers by Maggie D. Lalies Breakdown of academic impact, for papers by C.A. Korduba Breakdown of academic impact, for papers by Keith R. Jarvie Breakdown of academic impact, for papers by J. Gaál Breakdown of academic impact, for papers by P. A. Baumann Breakdown of academic impact, for papers by Steven Z. Whetzel
Rankless by CCL
2026